Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation
- PMID: 20150557
- PMCID: PMC2845445
- DOI: 10.1161/ATVBAHA.109.202051
Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation
Abstract
Objective: The balance between apoptosis susceptibility and efferocytosis of macrophages is central to plaque remodeling and inflammation. LRP-1 and its ligand, apolipoprotein E, have been implicated in efferocytosis and apoptosis in some cell types. We investigated the involvement of the macrophage LRP-1/apolipoprotein E axis in controlling plaque apoptosis and efferocytosis. Method and Results- LRP-1(-/-) macrophages displayed nearly 2-fold more TUNEL positivity compared to wild-type cells in the presence of DMEM alone or with either lipopolysaccharide or oxidized low-density lipoprotein. The survival kinase, phosphorylated Akt, was barely detectable in LRP-1(-/-) cells, causing decreased phosphorylated Bad and increased cleaved caspase-3. Regardless of the apoptotic stimulation and degree of cell death, LRP-1(-/-) macrophages displayed enhanced inflammation with increased IL-1 beta, IL-6, and tumor necrosis factor-alpha expression. Efferocytosis of apoptotic macrophages was reduced by 60% in LRP-1(-/-) vs wild-type macrophages despite increased apolipoprotein E expression by both LRP-1(-/-) phagocytes and wild-type apoptotic cells. Compared to wild-type macrophage lesions, LRP-1(-/-) lesions had 5.7-fold more necrotic core with more dead cells not associated with macrophages.
Conclusions: Macrophage LRP-1 deficiency increases cell death and inflammation by impairing phosphorylated Akt activation and efferocytosis. Increased apolipoprotein E expression in LRP-1(-/-) macrophages suggests that the LRP-1/apolipoprotein E axis regulates the balance between apoptosis and efferocytosis, thereby preventing necrotic core formation.
Conflict of interest statement
Figures






Similar articles
-
Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation.Circ Res. 2019 Feb 15;124(4):e6-e19. doi: 10.1161/CIRCRESAHA.118.313028. Circ Res. 2019. PMID: 30595089 Free PMC article.
-
Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.Circulation. 2018 Oct 23;138(17):1850-1863. doi: 10.1161/CIRCULATIONAHA.117.031702. Circulation. 2018. PMID: 29794082 Free PMC article.
-
PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.Atherosclerosis. 2018 Sep;276:171-181. doi: 10.1016/j.atherosclerosis.2018.05.009. Epub 2018 May 16. Atherosclerosis. 2018. PMID: 29853191
-
Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis.Circ J. 2016 Oct 25;80(11):2259-2268. doi: 10.1253/circj.CJ-16-0924. Epub 2016 Oct 8. Circ J. 2016. PMID: 27725526 Free PMC article. Review.
-
Mechanisms and consequences of efferocytosis in advanced atherosclerosis.J Leukoc Biol. 2009 Nov;86(5):1089-95. doi: 10.1189/jlb.0209115. Epub 2009 May 4. J Leukoc Biol. 2009. PMID: 19414539 Free PMC article. Review.
Cited by
-
The unfolded protein response is a major mechanism by which LRP1 regulates Schwann cell survival after injury.J Neurosci. 2011 Sep 21;31(38):13376-85. doi: 10.1523/JNEUROSCI.2850-11.2011. J Neurosci. 2011. PMID: 21940431 Free PMC article.
-
Immune system and atherosclerosis: Hostile or friendly relationship.Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221092188. doi: 10.1177/03946320221092188. Int J Immunopathol Pharmacol. 2022. PMID: 35410514 Free PMC article. Review.
-
Efferocytosis in health and disease.Nat Rev Immunol. 2020 Apr;20(4):254-267. doi: 10.1038/s41577-019-0240-6. Epub 2019 Dec 10. Nat Rev Immunol. 2020. PMID: 31822793 Free PMC article. Review.
-
Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology.Immunity. 2019 May 21;50(5):1149-1162. doi: 10.1016/j.immuni.2019.04.018. Immunity. 2019. PMID: 31117011 Free PMC article. Review.
-
LRP1 Regulates Retinal Angiogenesis by Inhibiting PARP-1 Activity and Endothelial Cell Proliferation.Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):350-60. doi: 10.1161/ATVBAHA.115.306713. Epub 2015 Dec 3. Arterioscler Thromb Vasc Biol. 2016. PMID: 26634655 Free PMC article.
References
-
- Herz J, Clouthier DE, Hammer RE. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell. 1992;71:411–421. - PubMed
-
- Overton CD, Yancey PG, Major AS, Linton MF, Fazio S. Deletion of Macrophage LDL Receptor-Related Protein Increases Atherogenesis in the Mouse. Circ Res. 2007;100:670–677. - PubMed
-
- Li Y, Gerbod-Giannone MC, Seitz H, Cui D, Thorp E, Tall AR, Matsushima GK, Tabas I. Cholesterol-induced apoptotic macrophages elicit an inflammatory response in phagocytes, which is partially attenuated by the Mer receptor. J Biol Chem. 2006;281:6707–6717. - PubMed
-
- Boullier A, Li Y, Quehenberger O, Palinski W, Tabas I, Witztum JL, Miller YI. Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages. Arterioscler Thromb Vasc Biol. 2006;26:1169–1176. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous